Clinical Trial Update: Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV [NA]

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of rivaroxaban for acute non-neoplastic portal vein thrombosis in patients with hepatitis C virus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Portal Vein Thrombosis

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Zagazig University | Conditions: Portal Vein Thrombosis | NA | Status: COMPLETED